Boston Scientific Corp. won CE Mark approval from the European Union for its for its Latitude Patient Management remote patient monitoring system.
The Natick devices giant said the system is designed to keep tabs on patients with implanted cardiac devices, logging data on the devices and the patients’ hearts, detecting clinical events and sending the information directly to physicians.
The product will be rolled out in a phased launch in Europe beginning this week. More than 130,000 patients are using the system in the United States, where it hit the market in 2006.